[Click eStock] "AI Healthcare Market Blossoms... Spotlight on Infinite Healthcare"

[Asia Economy Reporter Ji Yeon-jin] Kiwoom Securities announced on the 20th that the integration of medical big data is a global trend, and as the artificial intelligence healthcare market is beginning in earnest, it is necessary to pay attention to Infinite Healthcare, which possesses core technologies in this field.

Infinite Healthcare was established in 2002 through the newly merged Mediface and 3Dmed, and is the number one company in the domestic medical Picture Archiving and Communication System (PACS) market share. It was listed on the KOSDAQ market in 2010 and currently provides services to over 6,300 medical institutions in 55 countries through its domestic headquarters and nine overseas subsidiaries.

The representative product, PACS, digitizes images taken by medical imaging acquisition devices, storing them simultaneously with shooting, allowing specialists to view and interpret them in real time. Currently, medical information systems are evolving from Electronic Medical Records (EMR) to Electronic Health Records (EHR) and Personal Health Records (PHR).

To utilize medical big data, the process of data generation → integration → analysis is necessary. In addition to PACS, the company provides a medical data integration platform (INFINITT Healthcare Platform) that can manage generated data in an integrated manner. The core competitiveness and future growth momentum are expected to come from the ability to offer an efficient diagnostic workflow service for the entire process by installing AI diagnostic solutions from medical AI diagnostic solution companies on the company’s platform.

The global artificial intelligence healthcare market is expected to grow from $4.9 billion last year to approximately $45.4 billion by 2026, raising the possibility of additional collaborations with AI diagnostic solution companies.

Kim Sang-pyo, a researcher at Kiwoom Securities, said, "The key investment points of Infinite Healthcare are its ability to generate stable revenue based on services, scalability through collaboration with AI diagnostic solution companies, and growth potential in the EHR market through a strong distribution network. Based on a powerful domestic and international distribution network, the company’s scalability through its own medical data integration platform is also considered a point to watch."

This content was produced with the assistance of AI translation services.